2014 annual financial data
BioCryst Pharmaceuticals 2014 Operating margin
Direct answer
Operating margin was -336.35%.
Operating income was -45,771,000 USD and net income was -45,189,000 USD.
Operating cash flow was -38,551,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,608,000 USD
- Operating income
- -45,771,000 USD
- Net income
- -45,189,000 USD
- Operating cash flow
- -38,551,000 USD